1,233 Shares in The Clorox Company (NYSE:CLX) Acquired by Houlihan Financial Resource Group Ltd.

Houlihan Financial Resource Group Ltd. bought a new position in shares of The Clorox Company (NYSE:CLXFree Report) in the third quarter, HoldingsChannel.com reports. The firm bought 1,233 shares of the company’s stock, valued at approximately $201,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Kerusso Capital Management LLC boosted its position in Clorox by 6.4% during the third quarter. Kerusso Capital Management LLC now owns 19,011 shares of the company’s stock valued at $3,097,000 after purchasing an additional 1,148 shares in the last quarter. Lindbrook Capital LLC lifted its position in shares of Clorox by 9.9% during the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after buying an additional 88 shares during the last quarter. Townsend & Associates Inc boosted its holdings in shares of Clorox by 4.0% in the 3rd quarter. Townsend & Associates Inc now owns 11,955 shares of the company’s stock valued at $1,901,000 after buying an additional 464 shares in the last quarter. Rovin Capital UT ADV purchased a new position in shares of Clorox in the 3rd quarter worth approximately $393,000. Finally, CWA Asset Management Group LLC bought a new position in shares of Clorox during the 3rd quarter worth approximately $449,000. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CLX. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the stock from $155.00 to $170.00 in a report on Wednesday. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Deutsche Bank Aktiengesellschaft boosted their price target on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Evercore ISI decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Finally, Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $155.00.

Check Out Our Latest Analysis on CLX

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is owned by corporate insiders.

Clorox Stock Performance

CLX opened at $165.16 on Friday. The stock has a market cap of $20.44 billion, a P/E ratio of 57.55, a P/E/G ratio of 3.01 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a fifty day moving average price of $162.14 and a 200 day moving average price of $146.83. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The company’s revenue was up 27.0% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.95%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s payout ratio is 170.04%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.